theranos

Waren und Dienstleistungen

01 Reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); chemical preparations for scientific purposes; reagents for chemical analysis; diagnostic kits (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); testing kits containing reagents used in analyzing and detecting certain toxins for clinical or medical laboratory use; genetic identity tests comprised of reagents; antibodies for in vitro scientific or research use; biochemicals (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); biomedical compounds (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); chemical preparations to be used in biochemical and clinical research; diagnostic preparations for clinical or medical laboratory use (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations)

05 Biological and chemical preparations for medical or veterinary use; reagents and media for medical or veterinary purposes; clinical medical reagents; biological and chemical preparations, namely, antibodies for clinical, medical or veterinary use to detect and analyze substances; diagnostic kits for medical or veterinary use (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); diagnostic preparations for medical or veterinary purposes; testing kits for testing bodily fluids (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); medical diagnostic test kits comprised of reagents and assays for testing of body fluids; medical diagnostic and monitoring test strips for use in the treatment of a wide variety of diseases and health disorders; test strips for medical and laboratory analysis of blood; ovulation test kits (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); biological tissue cultures for medical or veterinary purposes; culture media for cultivating blood cells

09 Computer software; computer software for medical monitoring and analysis of medical data; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; mobile electronic devices (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); electronic publications

10 Medical devices; medical devices, namely, point of care and handheld devices for analysis of drugs, proteins and other substances, and wireless transfer of medical data; medical measuring apparatus; medical measuring apparatus, namely, cartridges for use with therapies or equipment for medical monitoring and analysis of substances; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for clinical diagnosis; capillary reagent tubes; capillary tubes for blood; capillary tubes for samples; containers especially made for processing blood samples; containers for medical waste; devices for monitoring blood sugar; diagnostic apparatus for the detection of a wide variety of diseases; health monitoring devices; medical diagnostics apparatus; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; patient medical monitors for monitoring a wide variety of physical conditions and diseases; home or portable monitors for monitoring a wide variety of physical conditions and diseases

35 Administering pharmacy reimbursement programs and services; administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; medical referrals (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); physician referrals (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); medical billing support services; providing an internet-based database of patient medical information designed to facilitate sharing and maintenance of patient medical information between and amongst the patient, insurers and healthcare professionals providing services to the patient; providing an internet-based system for confirming patient identity, eligibility and authorization for health insurance or medicare/medicaid services; maintaining patient medical records and files

36 Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services

39 Biomedical services, namely, storage of medical data; biomedical services, namely, the storage of human cells for medical use; consulting services in the field of air medical operations in the nature of air medical transport; medical transport services; transportation of medical waste and special waste

42 Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical laboratories (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); medical laboratory services (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing a web site featuring technology that enables patients, physicians and other healthcare providers to generate, manage and exchange medical information (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); Software as a Service (SaaS) for medical and disease analysis

44 Medical evaluation services; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services; health care; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes; providing information in the field of pet health; pet hospital services; providing a web site featuring medical information (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); providing a website featuring health and healthcare information; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary special services; medical and veterinary services; biomedical services; advisory, consultative and telephone helpline services relating to the use of apparatus, instruments and test kits diagnostic testing, self testing, self monitoring and testing for adverse drug reactions

Übersetzung anzeigen

Markenform	Bildmarke
Aktenzeichen	1215178
Länder
Basismarke	Nr. 85960653, 14. Juni 2013

Anmeldedatum	14. Dezember 2013
Ablaufdatum	19. März 2018

Datum	Belegnummer	Bereich	Eintrag
26. September 2018	2018/42 Gaz	US	RAW: Total Ceasing Effect
27. Juni 2018	2018/28 Gaz	PH	RAW: Total Invalidation
22. März 2017	2017/28 Gaz	SG	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. Februar 2017	2017/13 Gaz	PH	RAW: Rule 18ter(2)(i) GP following a provisional refusal
04. Juli 2016	2016/46 Gaz	IL	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
19. April 2016	2016/17 Gaz	AU	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
07. April 2016	2016/17 Gaz	JP	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. Januar 2016	2016/3 Gaz	IL	Ablehnung
25. Dezember 2015	2016/2 Gaz	RU	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
16. November 2015	2015/47 Gaz	KR	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. Oktober 2015	2015/42 Gaz	IN	Ablehnung
06. Oktober 2015	2015/43 Gaz		RAW: Limitation
28. August 2015	2015/36 Gaz	RU	Ablehnung
31. Juli 2015	2015/32 Gaz	MX	Ablehnung
28. Juli 2015	2015/35 Gaz	CN	Ablehnung
15. Juni 2015	2015/25 Gaz	CH	Ablehnung
20. März 2015	2015/13 Gaz	NO	Ablehnung
11. März 2015	2015/13 Gaz	SG	Ablehnung
05. Februar 2015	2015/7 Gaz	PH	Ablehnung
05. Februar 2015	2015/6 Gaz	JP	Ablehnung
22. Januar 2015	2015/4 Gaz	KR	Ablehnung
07. Oktober 2014	2014/41 Gaz	AU	Ablehnung
14. Dezember 2013	2014/34 Gaz	US	Eintragung

Schützen Sie diese Marke vor Nachahmern!

Markendetails Letztes Update: 19. Oktober 2018

Markeninhaber

Markenvertreter

Waren und Dienstleistungen

Markenhistorie